Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Tetrapharm Bioengineering ApS
APS
Active
CVR 46672909
Ørestads Boulevard 108, 2300
København S
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2026 · <1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Tetrapharm Bioengineering ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JB
Jesper Breum
Management
Management
2026
MS
Martin Stefan Rose
Management
Management
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
RS
Rolf Sass Sørensen
Board of Directors
Board of Directors
2026
JB
Jesper Breum
Board of Directors
Board of Directors
2026
CB
Claus Berner Nielsen
Deputy Chairman
Deputy Chairman
2026
SM
Søren Maarssø
Chairman
Chairman
2026
Shareholders
As of last annual report
Tetra Pharm Technologies ApS — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Tetra Pharm Technologies ApS
Company
100%
100%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Tetrapharm Bioengineering ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
